First Western Capital Management’s AbbVie ABBV Stock Holding History

First Western Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$236K	Hold	2,694	–	–	5.01%	13
2020 Q2	$265K	Hold	2,694	–	–	5.98%	7
2020 Q1	$205K	Sell	2,694 -31	-1%	-$2.64K	6.16%	12
2019 Q4	$241K	Hold	2,725	–	–	3.83%	14
2019 Q3	$206K	Sell	2,725 -616	-18%	-$42.2K	3.21%	23
2019 Q2	$243K	Sell	3,341 -336	-9%	-$26.4K	3.23%	24
2019 Q1	$296K	Sell	3,677 -2,236	-38%	-$183K	4.21%	12
2018 Q4	$545K	Sell	5,913 -2,612	-31%	-$230K	4.95%	2
2018 Q3	$806K	Sell	8,525 -492	-5%	-$46.7K	3.62%	5
2018 Q2	$835K	Buy	9,017 +1,310	+17%	+$128K	3.78%	4
2018 Q1	$729K	Sell	7,707 -2,500	-24%	-$275K	3.46%	4
2017 Q4	$987K	Sell	10,207 -65	-0.6%	-$6.13K	0.56%	41
2017 Q3	$913K	Sell	10,272 -1,084	-10%	-$82.5K	0.55%	40
2017 Q2	$823K	Sell	11,356 -2,279	-17%	-$153K	0.5%	42
2017 Q1	$888K	Sell	13,635 -10,118	-43%	-$636K	0.54%	43
2016 Q4	$1.49M	Sell	23,753 -22,065	-48%	-$1.35M	0.81%	44
2016 Q3	$2.89M	Sell	45,818 -5,798	-11%	-$375K	1.13%	38
2016 Q2	$3.2M	Sell	51,616 -6,424	-11%	-$391K	1.17%	35
2016 Q1	$3.31M	Buy	58,040 +1,959	+3%	+$109K	1.18%	37
2015 Q4	$3.32M	Buy	56,081 +4,245	+8%	+$245K	1.04%	44
2015 Q3	$2.82M	Sell	51,836 -2,603	-5%	-$169K	0.94%	51
2015 Q2	$3.66M	Buy	54,439 +1,793	+3%	+$117K	1.17%	32
2015 Q1	$3.08M	Buy	52,646 +16,481	+46%	+$996K	0.93%	46
2014 Q4	$2.37M	Buy	+36,165	New	+$2.28M	0.7%	60

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

First Western Capital Management's ABBV Position: Q3 2020 in Review

First Western Capital Management held its AbbVie (ABBV) position steady in Q3 2020 at 2,694 shares worth $236K. The position accounts for 5.01% of the portfolio, ranked #13.

First Western Capital Management first reported a position in ABBV in Q4 2014 and has held it in 24 quarters since. The position peaked at $3.66M in Q2 2015. 2,367 funds tracked by Wall St. Rank hold ABBV as of Q3 2020.

First Western Capital Management held 2,694 shares of AbbVie worth $236K as of Q3 2020.
First Western Capital Management left its AbbVie share count unchanged in Q3 2020.
AbbVie made up 5.01% of First Western Capital Management's portfolio in Q3 2020, its #13 holding.
First Western Capital Management first reported a position in AbbVie in Q4 2014 and has held it in 24 quarters since.
First Western Capital Management's AbbVie position peaked at $3.66M in Q2 2015.
2,367 funds tracked by Wall St. Rank held AbbVie as of Q3 2020.

Based on First Western Capital Management's 13F filing for Q3 2020, filed 18 Nov 2020.